Clinical Trial Update: A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart [Phase 3]

View source ↗

Summary

A Phase 3 trial to test Vicadrostat (BI-690517) in combination with empagliflozin for heart failure with reduced left ventricular function. The study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Empagliflozin (Jardiance) (empagliflozin)
• Vicadrostat

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Heart Failure | Phase 3 | Status: RECRUITING